Behavioral Science

Index
A
Abnormal thought formation, 88
Abuse. See also Substance abuse
child, 57–60
domestic partner, 60
elder, 57–60
emotional, 59–60
sexual, 58–59
Acceptance, as stage of dying, 21
Accuracy, 204
Accutane, 94
Acetylcholine, 80–81
Acting out, as defense mechanism, 30
Active suicidal ideation, 67
Acute stress disorder (ASD), 103, 108
ADHD (attention-deficit hyperactivity
disorder), 162
Adjustment disorder, 108–110
Adolescence, 12
Adoption, children’s knowledge of, 12
Adoption study, 69
Adulthood, 15–17
Advance directive, 184
Aggression, 62–63
Aging, 19–20. See also Elderly
memory and, dementia v., 113
physiologic changes, in males, 17
Agnosia, 112
Agoraphobia, 103, 105
Agranulocytosis, 171–172
Alcohol abuse, 148–150. See also Substance
abuse
chronic effects, 149
ethanol
liver metabolism limits, 149
toxicity, 143
genetic factors for, 72
HVA and, 79
relapse rate, 150
screening for, 148
sexual response and, 55–56
thiamine deficiency, 115
tolerance types, 149
toxic effects, 149
in twins, 72
withdrawal, 141, 143
with benzodiazepines, 150
benzodiazepines for, 166
with disulfiram, 141
DTs, 150
Alcohol abuse, withdrawal (Cont.):
hallucinations, 150
seizures, 150
symptoms, 150
α (type I) error, 212
Alternative hypothesis (H 1 ), 212
Altruism, as defense mechanism, 27, 30
Alzheimer disease
brain changes, postmortem, 114
cholinergic neuron decrease, 81
clinical course, 113
dementia and, 113–114
genetic factors, 71
medications, 114
neuropeptides, 82
risk factors, 114
sleep patterns, 48
vascular dementia v., 113
Amenorrhea, 153
from antipsychotics, 172
Amines, 78–81. See also Acetylcholine;
Dopamines; Serotonin
γ -Aminobutyric acid (GABA), 63, 81
Amnestic syndromes, 115
brain structures affected, 115
dementia v., 115
Amphetamines, 55, 144. See also Substance
abuse
Amygdala lesion, 76
Anaclitic depression, 11
Anal phase, 4
Analysis of variance (ANOVA), 214–215
Androgen insensitivity, 50
Anemia, 153–154
Anger, as stage of dying, 21
Anhedonia, 93, 141
Anorexia nervosa, 121, 153–154
bulimia nervosa v., 153
medical effects of, 153–154
treatment, 154
ANOVA (analysis of variance), 214–215
Antipsychotics, 171–172
amenorrhea from, 172
antitypical
mechanism of action, 171
side effects, 171
for delirium, 112
histamine blocking, 80
for NMS, 91
for schizophrenia, 90
217